HOWL insider transactions
Werewolf Therapeutics Inc. (HOWL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
HOWL insiders
Everyone who has filed a Form 4 or 5 at Werewolf Therapeutics Inc., latest first. Follow anyone to get their next filing.
- Luke EvninDirector, 10% owner+$2.41M-$3.26M
- Ra Capital Management, L.P.Director, 10% owner+$36.2M-$964K
- MPM BioVentures 2014, L.P.Former 10% Owner, 10% owner+$2.01M-$2.23M
- Ansbert GadickeFormer 10% Owner, 10% owner+$3.92M-$2.09M
- Briggs MorrisonDirector
- Alon LazarusDirector
- Meeta ChatterjeeDirector
- Michael A. ShermanDirector
- Anil K. SinghalDirector
- Michael B. AtkinsDirector
- Steven H. BloomChief Business Officer
- Ellen LubmanChief Business Officer
- Timothy W. TrostChief Financial Officer
- Randi IsaacsChief Medical Officer
- Chulani KarunatilakeChief Technology Officer
- Daniel J HicklinOfficer, Director
- Derek DiRoccoDirector
- Cynthia Seidel-DuganChief Scientific Officer
- Reid LeonardOfficer-$40.2K
Recent Form 3, 4, and 5 filings for HOWL
- Director Evnin Luke sold $44,749 worth of shares (143,199 units at $0.31) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $47,125 worth of shares (157,084 units at $0.30) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Ra Capital Management, L.P. sold $145,919 worth of shares (416,911 units at $0.35) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Ra Capital Management, L.P. sold $173,758 worth of shares (448,836 units at $0.39) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Ra Capital Management, L.P. sold $253,569 worth of shares (678,226 units at $0.37) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $28,463 worth of shares (76,928 units at $0.37) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $43,029 worth of shares (105,565 units at $0.41) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $63,628 worth of shares (139,803 units at $0.46) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $66,200 worth of shares (141,106 units at $0.47) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $86,560 worth of shares (191,762 units at $0.45) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $76,363 worth of shares (171,049 units at $0.45) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $24,127 worth of shares (44,679 units at $0.54) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $280,210 worth of shares (407,574 units at $0.69) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Ra Capital Management, L.P. sold $390,688 worth of shares (565,167 units at $0.69) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $64,217 worth of shares (100,581 units at $0.64) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $198,310 worth of shares (274,619 units at $0.72) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $154,525 worth of shares (205,911 units at $0.75) as part of a pre-agreed trading plan (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- New insider Urban Michael J. claimed ownership of 5,284 shares (SEC Form 3)3 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $20,942 worth of shares (38,782 units at $0.54) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $61,787 worth of shares (111,227 units at $0.56) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $53,533 worth of shares (91,374 units at $0.59) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $45,882 worth of shares (71,054 units at $0.65) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $48,431 worth of shares (78,377 units at $0.62) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $185,221 worth of shares (291,283 units at $0.64) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $51,951 worth of shares (48,171 units at $1.08) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $88,587 worth of shares (82,971 units at $1.07) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $94,787 worth of shares (95,179 units at $1.00) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $117,623 worth of shares (128,185 units at $0.92) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Former 10% Owner Mpm Bioventures 2014, L.P. sold $183,275 worth of shares (199,732 units at $0.92) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Former 10% Owner Gadicke Ansbert sold $183,275 worth of shares (199,732 units at $0.92) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $87,833 worth of shares (91,088 units at $0.96) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Mpm Bioventures 2014, L.P. sold $136,855 worth of shares (141,927 units at $0.96) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- SEC Form 4 filed by Werewolf Therapeutics Inc.4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $115,234 worth of shares (125,576 units at $0.92) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Mpm Bioventures 2014, L.P. sold $179,551 worth of shares (195,666 units at $0.92) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Gadicke Ansbert sold $179,551 worth of shares (195,666 units at $0.92) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $94,930 worth of shares (102,753 units at $0.92) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Mpm Bioventures 2014, L.P. sold $147,913 worth of shares (160,103 units at $0.92) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Gadicke Ansbert sold $147,913 worth of shares (160,103 units at $0.92) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $128,785 worth of shares (134,553 units at $0.96) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Mpm Bioventures 2014, L.P. sold $200,665 worth of shares (209,652 units at $0.96) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Gadicke Ansbert sold $200,665 worth of shares (209,652 units at $0.96) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $154,850 worth of shares (137,041 units at $1.13) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Mpm Bioventures 2014, L.P. sold $241,278 worth of shares (213,529 units at $1.13) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Gadicke Ansbert sold $241,278 worth of shares (213,529 units at $1.13) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $189,830 worth of shares (155,885 units at $1.22) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Mpm Bioventures 2014, L.P. sold $295,781 worth of shares (242,890 units at $1.22) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Gadicke Ansbert sold $295,781 worth of shares (242,890 units at $1.22) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $251,349 worth of shares (189,356 units at $1.33) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Mpm Bioventures 2014, L.P. sold $391,636 worth of shares (295,043 units at $1.33) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Gadicke Ansbert sold $391,636 worth of shares (295,043 units at $1.33) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Director Evnin Luke sold $286,497 worth of shares (177,145 units at $1.62) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Mpm Bioventures 2014, L.P. sold $446,403 worth of shares (276,017 units at $1.62) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- Large owner Gadicke Ansbert sold $446,403 worth of shares (276,017 units at $1.62) (SEC Form 4)4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- SEC Form 4 filed by Director Evnin Luke4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- SEC Form 4 filed by Director Morrison Briggs4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- SEC Form 4 filed by Director Lazarus Alon4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- SEC Form 4 filed by Director Chatterjee Meeta4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- SEC Form 4 filed by Director Atkins Michael B.4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
- SEC Form 4 filed by Director Singhal Anil K.4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)